Welcome to our dedicated page for Labcorp Holdings news (Ticker: LH), a resource for investors and traders seeking the latest updates and insights on Labcorp Holdings stock.
Labcorp Holdings Inc (LH) delivers essential clinical diagnostics and advanced laboratory solutions that shape modern medical decision-making. This dedicated news hub provides investors and healthcare professionals with timely updates on Labcorp's operational developments, scientific advancements, and strategic initiatives.
Access curated press releases and analysis covering earnings reports, partnership announcements, and innovations in precision oncology diagnostics. Track Labcorp's progress in genomic sequencing technologies and biopharma collaborations through verified updates from primary sources.
The resource consolidates critical information about Labcorp's laboratory network expansions, regulatory milestones, and service enhancements across clinical testing and drug development sectors. Users gain insights into how the company maintains its leadership through scientific rigor and operational scale.
Bookmark this page for streamlined access to Labcorp's evolving role in healthcare innovation, with updates organized for efficient navigation. Return regularly to stay informed about developments impacting diagnostic capabilities and research partnerships in the life sciences sector.
Labcorp (NYSE: LH) has launched the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small businesses, facilitating COVID-19 testing for companies with up to 120 employees. The initiative allows bulk purchasing to save on shipping costs and provides necessary testing for safe operations as businesses reopen. The kits can be self-administered and results are available within 1-2 days. Although the test is authorized under emergency use by the FDA, it reflects Labcorp's commitment to expand access to testing and support community health.
Labcorp (NYSE: LH) has announced its Annual Meeting of Shareholders, set to be webcast live on May 12 at 9:00 a.m. ET via www.Labcorp.com. An archived replay will be available for one year. Labcorp is a prominent global life sciences company that provides crucial information to aid healthcare professionals and patients in decision-making. With over 70,000 employees and a reported revenue of $14 billion in FY2020, Labcorp continues to innovate in diagnostics and drug development.
Labcorp (NYSE: LH) is set to announce its first quarter 2021 financial results before market opening on April 29, 2021. The company will host a conference call at 9:00 a.m. ET to discuss the results, which will be available on the Labcorp Investor Relations website. An audio replay will be accessible until May 13, 2021. Labcorp, a prominent global life sciences firm, reported $14 billion in revenue for FY2020, emphasizing its capability in diagnostics and drug development. The release includes forward-looking statements about COVID-19's impact on business operations.
Labcorp (NYSE: LH) announced the appointment of Kathryn Wengel, previously Executive Vice President at Johnson & Johnson, to its Board of Directors, expanding the board from 9 to 10 members. Wengel brings over 30 years of experience in managing healthcare organizations and global supply chains, which Labcorp anticipates will enhance its operational capabilities. Labcorp's Chairman and CEO, Adam Schechter, emphasized the importance of diverse perspectives in the boardroom, aiming to strengthen the company’s mission in healthcare.
Labcorp (NYSE: LH) has announced its ongoing efforts to enhance its business strategy and capital allocation to unlock shareholder value. The company is making significant advancements in diagnostics and drug development, particularly in areas like oncology and COVID-19. To facilitate this review, Labcorp's Board of Directors has engaged Goldman Sachs & Co. LLC as a financial advisor. The company emphasizes its commitment to improving patient health and its role in combating COVID-19.
Labcorp (NYSE: LH) announces that Dr. Marcia Eisenberg, chief scientific officer, has been honored as a 2021 Luminary by the Healthcare Businesswomen’s Association (HBA). Dr. Eisenberg's recognition celebrates over 30 years of contributions to healthcare innovation and her support for women in STEM. She has played a pivotal role in the commercialization of PCR testing and COVID-19 diagnostics. The honor will be conferred during the virtual Woman of the Year event on May 6. Labcorp reported $14.0 billion in revenue for FY2020.
Labcorp (NYSE: LH) announced that its executive management team will participate in a virtual fireside chat at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum on March 24 at 2:00 p.m. ET. A live webcast of the presentation will be available on the company's website and archived for later viewing.
Labcorp is a global life sciences leader, providing essential diagnostic and drug development services. The company reported revenue of $14 billion in FY2020 and serves clients in over 100 countries.
Labcorp (NYSE: LH) and PathAI have expanded their strategic partnership focusing on AI-powered pathology. This collaboration will enable seamless deployment of PathAI algorithms in clinical trials managed by Labcorp. Key objectives include enhancing patient stratification and developing companion diagnostic devices using robust AI-driven analytics. Labcorp aims to leverage this collaboration to advance drug development and improve patient outcomes, reflecting significant developments in digital pathology.
Walgreens has partnered with Labcorp to sell the Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter at 6,000 stores nationwide. Starting spring 2021, this will be Walgreens' first in-store testing option, enhancing access in underserved areas. Walgreens aims to increase its on-site testing capacity to over 5,000 locations by April 1. The kits allow customers to self-administer tests and send samples to Labcorp for processing. Test results will be available online, with follow-up by healthcare professionals for positive results.
FAQ
What is the current stock price of Labcorp Holdings (LH)?
What is the market cap of Labcorp Holdings (LH)?
